# Trade Mark Journal No.2026/013 27 March 2026

## WO0000001906843 (5)

Office of origin: United States of America

Date of International Registration:20 January 2026
Date of designation in the UK: 20 January 2026

International priority date claimed: 1 August 2025 (United States of America) (99315423)

Class 5
  Pharmaceutical preparations for the treatment of immune diseases and disorders, including psoriasis, lupus, and multiple sclerosis.

Alumis Inc.

Representative: Jessica L. Rothstein Goodwin Procter LLP, 620 Eighth Avenue, New York NY 10018, UNITED STATES OF AMERICA